Search
News Banner

Sunshine Heart News

Press Releases & News

The medical field is constantly changing and innovating. Keep up-to-date with the latest news about C-Pulse® and Sunshine Heart here.

Monday
Sep302013

Sunshine Heart Launches On-line Patient Resource Center for C-Pulse®’s U.S. Pivotal Trial

Sunshine Heart, Inc. (NASDAQ: SSH) today announced that it has launched a website dedicated to providing information to patients suffering from moderate to severe heart failure to learn about its C-Pulse U.S. pivotal trial, COUNTER HF™. The site offers patients and family members an interactive forum to learn about the C-Pulse system, including qualification criteria, a prescreening questionnaire, and information detailing how to enroll in the trial. For more information, visit: http://www.hfclinicalstudy.com/index.htm.

Click to read more ...

Thursday
Sep122013

Sunshine Heart Implants First Patient in C-Pulse® COUNTER HF™ U.S. Pivotal Trial

Sunshine Heart, Inc. (NASDAQ: SSH) announced today the first patient implant in the Company’s U.S. pivotal trial, COUNTER HF. The COUNTER HF study is a prospective, randomized, multi-center, controlled trial that will evaluate the safety and efficacy of the C-Pulse system for the treatment of NYHA Class III and ambulatory Class IV heart failure. Integral to the COUNTER HF study is the assessment of C-Pulse’s unique balloon counterpulsation treatment designed to improve heart function and reduce re-hospitalizations due to worsening heart failure.

Click to read more ...

Thursday
Sep122013

Sunshine Heart Implants First Patient in C-Pulse® COUNTER HF™ U.S. Pivotal Trial

Sunshine Heart, Inc. (NASDAQ: SSH) announced today the first patient implant in the Company’s U.S. pivotal trial, COUNTER HF. The COUNTER HF study is a prospective, randomized, multi-center, controlled trial that will evaluate the safety and efficacy of the C-Pulse system for the treatment of NYHA Class III and ambulatory Class IV heart failure. Integral to the COUNTER HF study is the assessment of C-Pulse’s unique balloon counterpulsation treatment designed to improve heart function and reduce re-hospitalizations due to worsening heart failure.

Click to read more ...

Wednesday
Aug282013

Sunshine Heart Announces Collaboration with Minnesota-based Minnetronix for Its C-Pulse® Fully Implantable System

August 12, 2013: Sunshine Heart, Inc. (NASDAQ: SSH) announced today a collaboration with St. Paul-based Minnetronix® for a transcutaneous energy transfer (“TET”) system to power the Company’s fully-implantable C-Pulse device under development. Minnetronix is a leader in med-device engineering, providing design and manufacturing support for many of the world’s largest medtech companies.

Click to read more ...

Thursday
Aug012013

CBS4 Minnesota's Jordana Green interviews David Rosa

Dave Rosa of Sunshine Heart talks about rining the opening bell at NASDAQ.

Hear the inteview here.

Page 1 2 3 4 5 ... 7